Credit Suisse Initiates Coverage On Amedisys with Outperform Rating, Announces $206 Price Target

Credit Suisse analyst A.J. Rice initiates coverage on Amedisys (NASDAQ:AMED) with a Outperform rating and a $206 price target.

Benzinga · 01/17/2020 12:51

Credit Suisse analyst A.J. Rice initiates coverage on Amedisys (NASDAQ:AMED) with a Outperform rating and a $206 price target.